Dare Bioscience, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Dare Bioscience, Inc. (DARE) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $407.53 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-03-26
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $407.53K.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $407.53K, a 13.74% increase from fiscal 2024.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $358.31K, a 72.25% decline from fiscal 2023.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $1.29M, a 120.40% increase from fiscal 2022.
- Dare Bioscience, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $585.94K, a 89.91% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 1 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $407.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $407.53K derived: sum of 2 quarters · filed 2026-03-26 | $407.53K derived: sum of 3 quarters · filed 2026-03-26 | $407.53K 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | $0.00 derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | -$41.69K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | -$41.69K derived: sum of 3 quarters · filed 2026-03-26 | $358.31K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$41.69K derived: sum of 2 quarters · filed 2025-11-13 | $358.31K 10-Q · filed 2025-11-13 | $1.65M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$41.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $358.31K 10-Q · filed 2025-08-14 | $1.65M derived: sum of 3 quarters · filed 2025-11-13 | $1.65M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $400.00K 10-K · filed 2026-03-26 | $400.00K 10-Q · filed 2025-11-13 | $358.31K 10-Q · filed 2024-05-14 | $1.69M derived: sum of 2 quarters · filed 2025-11-13 | $1.69M derived: sum of 3 quarters · filed 2025-11-13 | $1.69M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.29M derived: sum of 2 quarters · filed 2025-03-31 | $1.29M derived: sum of 3 quarters · filed 2025-03-31 | $1.29M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2024-08-12 | -$457.65K derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | -$457.65K derived: sum of 3 quarters · filed 2024-05-14 | -$457.65K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$457.65K derived: sum of 2 quarters · filed 2024-03-28 | -$457.65K derived: sum of 3 quarters · filed 2024-03-28 | $585.94K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$457.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$457.65K derived: sum of 2 quarters · filed 2023-11-09 | $585.94K 10-Q · filed 2023-11-09 | $585.94K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.04M 10-Q · filed 2023-08-10 | $1.04M derived: sum of 3 quarters · filed 2023-08-10 | $1.04M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $1.04M 10-Q · filed 2023-05-11 | $1.04M derived: sum of 2 quarters · filed 2023-05-11 | $1.04M derived: sum of 3 quarters · filed 2023-05-11 | $1.04M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $308.53K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $308.53K 10-Q · filed 2022-11-10 | $308.53K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $308.53K 10-Q · filed 2022-08-09 | $308.53K derived: sum of 3 quarters · filed 2022-08-09 | $308.53K derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $308.53K 10-Q · filed 2022-05-12 | $308.53K derived: sum of 2 quarters · filed 2022-05-12 | $308.53K derived: sum of 3 quarters · filed 2022-05-12 | $308.53K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $352.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $352.00K derived: sum of 3 quarters · filed 2021-08-12 | $352.00K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | $352.00K derived: sum of 2 quarters · filed 2021-05-13 | $352.00K derived: sum of 3 quarters · filed 2021-05-13 | $352.00K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $352.00K derived: sum of 2 quarters · filed 2021-03-30 | $352.00K derived: sum of 3 quarters · filed 2021-03-30 | $583.70K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $231.70K 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $231.70K 10-Q · filed 2020-08-12 | ||||
| 2019-03-31 | $231.70K 10-Q · filed 2020-05-14 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |